PC Magazine is your complete guide to computers, phones, tablets, peripherals and more. We test and review the latest gadgets ...

Investing.com -- aTyr Pharma (NASDAQ:ATYR) stock fell 80% after the company announced that its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis failed to meet its primary endpoint. The ...

Microsoft is working to resolve a bug that causes Defender for Endpoint to incorrectly tag some devices' BIOS (Basic Input/Output System) firmware as outdated, prompting users to update it. Microsoft ...

Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults with ...

I've been writing and editing stories for almost two decades that help people use technology and productivity techniques to work better, live better, and protect their privacy and personal data. As ...

Attila covers software, apps and services, with a focus on virtual private networks. He's an advocate for digital privacy and has been quoted in online publications like Computer Weekly, The Guardian, ...

The study did not meet the primary endpoint of change from baseline in mean daily oral corticosteroid dose at week 48. Topline data were announced from a phase 3 trial evaluating efzofitimod in ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Pilgrims and tourists rest in front of the ...

Positive high-level results from a pre-specified interim analysis of the Phase III TULIP-SC trial in patients with systemic lupus erythematosus (SLE) showed that the subcutaneous (SC) administration ...

The bootstrapped company will invest in an AI-powered unified enterprise platform combining configuration, compliance, patching, and vulnerability management. The Israeli company’s first funding round ...